Stress Urinary Incontinence

300 mcg testosterone patches or placebo applied twice weekly

Testosterone patch

Placebo

Charles R. Drew University of Medicine and Science

Testosterone Replacement in Postmenopausal Women With Stress Urinary Incontinence

This outcome will be assessed by MRI, urodynamic studies and pad tests.

This outcome will be evaluated with urodynamic measurement of urethral pressure (in cm H2O) along the urethra.

This outcome will be measured with a perineometer.

This will be measured with the Pad Test ( in a 24 hour period).

This outcome will be measured with a validated questionnaire and compared with the baseline before treatment.

These will be measured at the baseline (before treatment) and then every four weeks during the treatment and recovery periods and compared with the baseline.

The blood sample will be collected for laboratory measurement (CBC, chem 20, lipid profile) at the baseline (before treatment) and then every four weeks during the treatment and recovery periods and compared with the baseline.

Plan to share IPD: Presentation (grand rounds, scientific meetings) and peer-reviewed publications.

estradiol 17 beta/cough

Testosterone Replacement in Postmenopausal Women With Stress Urinary Incontinence

科学支持的最完整的草药数据库